CUSIP: 61240F108
Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,352,101
-
Share change
-
-470,159
-
Total reported value
-
$14,735,638
-
Price per share
-
$10.92
-
Number of holders
-
15
-
Value change
-
-$4,984,498
-
Number of buys
-
7
-
Number of sells
-
6
Quarterly Holders Quick Answers
What is CUSIP 61240F108?
CUSIP 61240F108 identifies MTRY - MONTEREY BIO ACQUISITION COR - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2023
-
Previous quarter:
Q1 2023
Recent filing periods for CUSIP 61240F108:
Institutional Holders of MONTEREY BIO ACQUISITION COR - COM (MTRY) as of Q2 2023
As of 30 Jun 2023,
MONTEREY BIO ACQUISITION COR - COM (MTRY) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,352,101 shares.
The largest 10 holders included
Periscope Capital Inc., Polar Asset Management Partners Inc., Owl Creek Asset Management, L.P., MIZUHO SECURITIES USA LLC, METEORA CAPITAL, LLC, RIVERNORTH CAPITAL MANAGEMENT, LLC, Walleye Capital LLC, AQR Arbitrage LLC, SkyView Investment Advisors, LLC, and FIR TREE CAPITAL MANAGEMENT LP.
This page lists
15
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.